Praluent Deal Combines Price Break With Point-Of Sale Rebates; Express Scripts Wants To Do More

 
• By Cathy Kelly

Express Scripts expects to develop similar coverage agreements, including point-of-sale rebates, with other manufacturers. Upcoming migraine drugs may be candidates.

More from Pricing Debate

More from Market Access